Paradigm Spine Advances Data-Driven Goals with PharmaPros Dataflow Manager
PharmaPros, a technical consulting and solutions provider specializing in data and workflow management for clinical trials, announced that Paradigm Spine, a provider of non-fusion and fusion spinal implant solutions, has selected the company's automated trial management solution, Dataflow Manager, for its coflex IDE clinical study, and future studies in the Paradigm Spine pipeline.
PharmaPros continues successful launch of Dataflow Manager in new and existing clients’ clinical trials
Cambridge, MA, September 22nd, 2008; PharmaPros, a technical consulting and solutions provider specializing in data and workflow management for clinical trials, today announced that Paradigm Spine, a provider of non-fusion and fusion spinal implant solutions, has selected the company’s automated trial management solution, Dataflow Manager, for its coflex IDE clinical study, and future studies in the Paradigm Spine pipeline.
Dataflow Manager is a first-in-class automated trial management solution that provides in-stream access to study status across the multiple systems and vendors being used to manage today’s complex clinical trials. Dataflow Manager automatically tracks the status of a trial against every data source in the study, (Labs, CRFs, EDC, IVRS, CTMS, ePRO, Images) and acts as a collaboration portal through which study teams can manage trials with an integrated view
of the study data.
With Dataflow Manager, Paradigm Spine will have one central interface through which to track and manage all of the clinical information for their coflex IDE study, including clinical data, safety data, medical images, site performance metrics, regulatory documents and reimbursement data.
“Paradigm Spine has been a forward-thinking PharmaPros client since 2005, and we are truly excited to be able to offer this solution. Paradigm Spine has challenged us to think about managing the lifecycle of data in new ways, and we are happy to return the favor with this new solution” said Peg Regan, CEO of PharmaPros Corporation.
With Dataflow Manager, Paradigm Spine will now be able to track coflex reimbursement claims activities, browse site regulatory documents for pre-audit preparations, adjudicate site payments based on performance, and extend the in stream workflow out to the investigator sites. Paradigm Spine statisticians will also be able to export integrated clinical data on-demand for in-stream analysis.
The Dataflow Manager solution will be supported by a PharmaPros Data Lifecycle Manager to assist Paradigm Spine in managing its aggressive timelines for interim-analysis and PMA filing.
”After careful evaluation of our internal needs and capacity, along with a thorough analysis of available external options, we found Dataflow Manager to provide a level of in-stream visibility unmatched by other solutions. In Dataflow Manager, we now have a solution that allows us to automate our best practices, manage the performance of our investigator sites more proactively, and effectively control costs. At Paradigm Spine, we have a philosophy of being data-driven, and Dataflow Manager allows us to stay true to that vision” said Marc Viscogliosi, CEO of Paradigm Spine.
About PharmaPros Corporation
PharmaPros Corporation is a technical consulting and solutions provider specializing in data and workflow management for clinical trials. Through its proprietary processes and tools, the company provides services to support the entire data lifecycle-enabling sponsor companies to effectively manage complex trials with multiple vendors and systems. PharmaPros was founded in 1996 and is headquartered in Cambridge, Massachusetts.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
